Table 1 Patient background data (n = 26)
Backgrounds median [interquartile range] or number (%) | Â |
|---|---|
Age, years | 65.5 [60.0-70.5] |
Male/Female | 4 (15.4) /22 (84.6) |
Weight, kg | 44.0 [41.7-47.7] |
BMI, kg/m2 | 18.0 [17.3-19.4] |
Smoking history | 3 (11.5) |
Mycobacterium species | |
  Mycobacterium avium complex | 23 (88.5) |
  M.avium, M.intracellulare | 22 (84.6), 1 (3.8) |
  Mycobacterium abscessus complex | 3 (11.5) |
Medical history | |
 Chronic obstructive pulmonary disease | 1 (3.8) |
 Bronchial asthma | 1 (3.8) |
 Interstitial pneumonia | 2 (7.7) |
 Bacterial pneumonia | 2 (7.7) |
 Old pulmonary tuberculosis | 1 (3.8) |
 Empyema | 1 (3.8) |
 Pulmonary aspergillosis | 1 (3.8) |
 Pneumothorax | 2 (7.7) |
 Rheumatoid arthritis | 4 (15.4) |
 Chronic sinusitis | 3 (11.5) |
Time from diagnosis until the initiation of treatment, months | 73.5 [38.5-131.0] |
Concomitant organisms at the initiation of inhaled AMK therapy | |
  Pseudomonas aeruginosa | 3 (11.5) |
  Aspergillus species | 3 (11.5) |